article thumbnail

New Sunscreen Ingredients: Unmet Needs and Key Considerations

The Dermatology Digest

New sunscreen ingredients are needed to help assuage patient safety concerns and lower skin cancer rates. 10% BEMT has been in use around the globe since 2000. Some new sunscreen ingredients are already approved in the European Union (EU) and are being studied in the US.

article thumbnail

Are phthalates something you really need to worry about in cosmetics? No.

The Eco Well Blog

The only phthalate still in use worldwide is diethyl phthalate, which can be used without restriction because of its good safety profile. While there is certainly a concern for some phthalates, particularly with endocrine disruption, the evidence we have to date regarding diethyl phthalate demonstrates safety. Kim, Min Kook, et al.

Safety 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

4 skin conditions caused by Covid-19 vaccine

First Derm

mRNA molecules cannot get into the cells on their own, therefore they are packaged in a polyethylene glycol (PEG) – 2000 containing lipid nanoparticles. Event monitoring of safety of COVID-19 vaccines still continues, and to date real-world data on skin reactions remain limited. They are also found in numerous medications.

article thumbnail

Hydroquinone creams, Vitamins in hair and more – episode 196

The Beauty Brains

However, the safety of this ingredient is a little controversial. Hydroquinone has been banned in cosmetic products in Europe since 2000. Additionally, melanocytes, the cells that make melanin, and organelles that contain melanin, can be destroyed. It’s pretty effective!

article thumbnail

Nattokinase vs Nattozimes: What's the Difference?

Aesthetics Advisor

In this clinical study ( Chen 2022 ) involving 1,062 participants, the objective was to examine the efficacy of NK (nattokinase) in atherosclerosis and hyperlipidemia and safety at the dose of 10,800 FU/day after 12 months of oral administration. This was reproduced in a similar study done by Oba and colleagues in 2021.

article thumbnail

Natto vs Nattokinase vs Nattozimes: What's the Difference?

Aesthetics Advisor

In this clinical study ( Chen 2022 ) involving 1,062 participants, the objective was to examine the efficacy of NK (nattokinase) in atherosclerosis and hyperlipidemia and safety at the dose of 10,800 FU/day after 12 months of oral administration. This was reproduced in a similar study done by Oba and colleagues in 2021.

article thumbnail

FLCCC I-CARE Early Treatment Protocol Review (2023)

Aesthetics Advisor

High-risk patients should consider: The combination of both HCQ and ivermectin Nattokinase 2000-4000 FU/day for 15 days OR Apixaban 5 mg daily for 15 days OR Rivaroxaban 10 mg daily for 15 days. The escalated use of anticoagulants should only be considered in patients with a low risk of bleeding.